title: Managing patients after myocardial infarction.
abstract: Thrombolytic therapy clearly saves lives when administered in the first critical hours after acute MI. Consequently, most patients can now be treated initially at the community hospital level. Transfer to a tertiary center may be reserved for those who become symptomatic after thrombolysis, which, of course, is not a panacea. Reducing the risks of reinfarction and death remain major issues.
authors.affiliation: Yale University.
authors.forename: L S
authors.initials: LS
authors.lastname: Cohen
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006334:Heart Function Tests; D006801:Humans; D009203:Myocardial Infarction / Q000534:rehabilitation / Q000628:therapy*; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D001241:Aspirin